Publications in High-Impact Journals

The following publications were co-authored by faculty, residents, or affiliates of the Duke Department of Head and Neck Surgery & Communication Sciences, and were published between March 2021 and May 2022 in peer-reviewed journals with impact factors of 10 or higher. The names of Duke faculty, residents, or affiliates are highlighted in bold.

Addressing the global burden of hearing loss.
Wilson BS, Tucci DL. Lancet. 2021;397(10278):945-947.

Advance care planning billing practices and documentation quality for cancer patients requiring hospitalization.
Berkowitz C, Ma J, Lowe JR, Dolor R. J Clin Oncol. 2021;39(15_suppl).

Aging-related olfactory loss is associated with olfactory stem cell transcriptional alterations in humans.
Oliva AD, Gupta R, Issa K, Abi Hachem R, Jang DW, Wellford SA, Moseman EA, Matsunami H, Goldstein BJ. J Clin Invest. 2022;132(4):e155506.

Association of changes in Medicaid dental benefits with localized diagnosis of oral cavity cancer.
Kana LA, Graboyes EM, Quan D, Grauer J, Osazuwa-Peters N, Barnes JM, Cramer JD. JAMA Oncol. 2022;8(5):778-780.

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Petit C, Lacas B, Pignon J-P, Le QT, Grégoire V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee J-W, Ghi MG, Sanguineti G, Temam S, Cheugoua-Zanetsie M, O’Sullivan B, Posner MR, Vokes EE, Cruz Hernandez JJ, Szutkowski Z, Lartigau E, Budach V, Suwiński R, Poulsen M, Kumar S, Ghosh Laskar S, Mazeron J-J, Jeremic B, Simes J, Zhong L-P, Overgaard J, Fortpied C, Torres-Saavedra P, Bourhis J, Aupérin A, Blanchard P, MACH-NC and MARCH Collaborative Groups (Brizel, D). Lancet Oncol. 2021;22(5):727-736.

Chronic Obstructive Pulmonary Disease Assessment in Primary Care to Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE): Multi-Method qualitative findings support implementation readiness of a new COPD screening tool in primary care practice.
Brown R, Isaac S, Tapp H, Dolor R, Knox L, Zittleman L, Elder N, Make BJ, Yawn BP, Han MK, Martinez F. TP41. TP041 DIAGNOSIS AND RISK ASSESSMENT IN COPD. 2021:isidoc:UA9IX

Corrigendum to ‘Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins’ [Redox Biol. 41 (2021) 101905].
Rashed FB, Stoica AC, MacDonald D, El-Saidi H, Ricardo C, Bhatt B, Moore J, Diaz-Dussan D, Ramamonjisoa N, Mowery Y, Damaraju S, Fahlman R, Kumar P, Weinfeld M. Redox Biol. 2021;44:101986.

Depression, chronic pain, and high-impact chronic pain among cancer survivors.
Osazuwa-Peters N, Polednik KM, Tutlam NT, Tait R, Scherrer J, Barnes JM, Schootman M, Adjei Boakye E. J Clin Oncol. 2021;39(15_suppl):12085-12085.

Differences in cardiovascular risk, Coronary Artery Disease, and cardiac events between Black and White individuals enrolled in the PROMISE Trial.
Zhang L, Olalere D, Mayrhofer T, Bittner DO, Emami H, Meyersohn NM, Puchner SB, Abidov A, Moloo J, Dolor RJ, Mark DB, Ferencik M, Hoffmann U, Douglas PS, Lu MT. JAMA Cardiol. 2022;7(3):259-267.

Differences in outcomes of mandatory motorcycle helmet legislation by country income level: A systematic review and meta-analysis.
Lepard JR, Spagiari R, Corley J, Barthélemy EJ, Kim E, Patterson R, Venturini S, Still MEH, Lo YT, Rosseau G, Mekary RA, Park KB. PLoS Med. 2021;18(9):e1003795.

Early Medicaid expansion and cancer mortality.
Barnes JM, Johnson KJ, Boakye EA, Schapira L, Akinyemiju T, Park EM, Graboyes EM, Osazuwa-Peters N. J Natl Cancer Inst. 2021;113(12):1714-1722.

Harnessing the power of artificial intelligence to transform hearing healthcare and research.
Lesica NA, Mehta N, Manjaly JG, Deng L, Wilson BS, Zeng FG. Nat Mach Intell. 2021;3(10):840-849.

Human Papillomavirus vaccination and trends in cervical cancer incidence and mortality in the US.
Tabibi T, Barnes JM, Shah A, Osazuwa-Peters N, Johnson KJ, Brown DS. JAMA Pediatr. 2022;176(3):313-316.

Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins.
Rashed FB, Stoica AC, MacDonald D, El-Saidi H, Ricardo C, Bhatt B, Moore J, Diaz-Dussan D, Ramamonjisoa N, Mowery Y, Damaraju S, Fahlman R, Kumar P, Weinfeld M. Redox Biol. 2021;41:101905.

Impact of machine learning-directed on-treatment evaluations on cost of acute care visits: Economic analysis of SHIELD-RT.
Natesan D, Thomas SM, Eisenstein E, Eclov N, Dalal N, Stephens SJ, Malicki M, Shields S, Cobb A, Mowery YM, Niedzwiecki D, Tenenbaum J, Palta M, Hong JC. J Clin Oncol. 2021;39(15_suppl):1509-1509.

Interpreting ORATOR: Lessons learned From a randomized comparison of primary surgical and radiation approaches for early-stage oropharyngeal cancer.
Mowery YM, Salama JK. J Clin Oncol. 2022;40(8):814-817.

Ipilimumab and radiation in patients with high-risk resected or regionally advanced melanoma.
Salama AKS, Palta M, Rushing CN, Selim MA, Linney KN, Czito BG, Yoo DS, Hanks BA, Beasley GM, Mosca PJ, Dumbauld C, Steadman KN, Yi JS, Weinhold KJ, Tyler DS, Lee WT, Brizel DM. Clin Cancer Res. 2021;27(5):1287-1295.

Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer (PaRTNer): Baseline financial toxicity and attitudes toward costs from a pilot study.
Chino F, Brizel DM, Mowery YM. J Clin Oncol. 2021;39(28_suppl):115-115.

Sociodemographic differences in patient-reported pain and pain management of head and neck cancer patients in a community oncology setting.
Osazuwa-Peters N, Larsen R, Patel A, Misra S, Pearson B, Smith B, Canick J, Kuziez D, Rohde RL. J Clin Oncol. 2021;39(28_suppl):150-150.

Stepped exercise program for patients with knee osteoarthritis : A randomized controlled trial.
Allen KD, Woolson S, Hoenig HM, Bongiorni D, Byrd J, Caves K, Hall KS, Heiderscheit B, Hodges NJ, Huffman KM, Morey MC, Ramasunder S, Severson H, Van Houtven C, Abbate LM, Coffman CJ. Ann Intern Med. 2021;174(3):298-307.

Suicide risk among melanoma and nonepithelial skin cancer patients: A Surveillance, Epidemiology, and End Results analysis.
Zahirsha Z, Barnes J, Simpson MC, Osazuwa-Peters N. JAAD. 2021;85(3).